Location History:
- San Francisco, CA (US) (1998)
- San Marino, CA (US) (2002 - 2017)
Company Filing History:
8 out of 639 
1 out of 15,502 
Years Active: 1998-2017
Title: The Innovative Contributions of Andrew A. Raubitschek
Introduction
Andrew A. Raubitschek is a distinguished inventor based in San Marino, California. With a profound expertise in biotechnology, he holds a remarkable portfolio of 8 patents, showcasing his innovative contributions to the field. His inventions primarily focus on advancements in recombinant antibody technology, significantly impacting therapeutic applications.
Latest Patents
One of Andrew's notable patents is titled "Covalent disulfide-linked diabodies and uses thereof." This invention introduces recombinant antibody fragments featuring a variable domain modified by a unique tail sequence added to its C-terminal end. The tail sequence, incorporating a terminal cysteine residue along with an amino acid spacer, is designed to maintain the fragment's target-binding affinity. Moreover, this invention encompasses pharmaceutical compositions that utilize these antibody fragments as delivery vehicles for agents aimed at targeted cells in subject organisms. Additionally, the invention extends to compositions for the in vitro detection and measurement of targeted molecules that bind to these fragments, facilitating the determination of the presence or quantity of such targets in biological samples through specific contact with the described compositions.
Career Highlights
Throughout his career, Andrew A. Raubitschek has been associated with prominent institutions that enhance his innovative endeavors. He has made substantial contributions while working at City of Hope and the University of California, where he forged his expertise in research and development.
Collaborations
Andrew's career is marked by fruitful collaborations with other esteemed professionals in the field. Notable among his coworkers are Anna M. Wu and Mark A. Sherman, whose combined efforts in research contribute to the advancement of innovative biotechnological solutions.
Conclusion
In summary, Andrew A. Raubitschek stands out as a pivotal figure in biotechnological innovation. His impressive patent portfolio and collaborations at notable institutions underline his commitment to advancing scientific knowledge and therapeutic developments. Through his inventions, he continues to pave the way for significant advancements in medical technology.